Cargando…

Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis

OBJECTIVES: To assess the evidence on the presence of antibodies cross-reactive with SARS-CoV-2 antigens in prepandemic samples from African populations. METHODS: We performed a systematic review and meta-analysis of studies evaluating prepandemic African samples using pre-set assay-specific thresho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ioannidis, John P.A., Contopoulos-Ioannidis, Despina G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266885/ https://www.ncbi.nlm.nih.gov/pubmed/37327857 http://dx.doi.org/10.1016/j.ijid.2023.06.009

Ejemplares similares

SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia
por: Manning, Jessica, et al.
Publicado: (2022)

SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia
por: Grassia, Jillian T., et al.
Publicado: (2022)

Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals
por: Johansson, Alexandra M., et al.
Publicado: (2021)

Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters
por: Ioannidis, John P.A., et al.
Publicado: (2020)

Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities
por: Ioannidis, John P.A., et al.
Publicado: (2021)

Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies
por: Axfors, Cathrine, et al.
Publicado: (2023)

Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review
por: Hirt, Julian, et al.
Publicado: (2023)

SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period
por: Baddal, Buket, et al.
Publicado: (2021)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples
por: Shrwani, Khalid, et al.
Publicado: (2021)

Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment
por: Panagiotou, Orestis A, et al.
Publicado: (2013)

Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey
por: Hemkens, Lars G, et al.
Publicado: (2016)

Age-stratified infection fatality rate of COVID-19 in the non-elderly population
por: Pezzullo, Angelo Maria, et al.
Publicado: (2023)

Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2020)

Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort
por: Choi, May Y, et al.
Publicado: (2022)

SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
por: Pilz, Stefan, et al.
Publicado: (2022)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions
por: Papanikolaou, George N, et al.
Publicado: (2001)

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
por: Contopoulos-Ioannidis, Despina G, et al.
Publicado: (2009)

Mother-to-child transmission of Chikungunya virus: A systematic review and meta-analysis
por: Contopoulos-Ioannidis, Despina, et al.
Publicado: (2018)

1622. Increase in Congenital Toxoplasmosis and Acute Toxoplasmosis Among Pregnant Women in the US during the COVID-19 pandemic
por: Contopoulos-Ioannidis, Despina, et al.
Publicado: (2023)

Toxoplasmosis and Schizophrenia: A Systematic Review and Meta‐Analysis of Prevalence and Associations and Future Directions
por: Contopoulos‐Ioannidis, Despina G., et al.
Publicado: (2022)

A Prepandemic Warning!
por: Webster, Robert G.
Publicado: (2020)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

International ranking systems for universities and institutions: a critical appraisal
por: Ioannidis, John PA, et al.
Publicado: (2007)

Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis
por: Holubar, Marisa, et al.
Publicado: (2017)

Acute Toxoplasma gondii Infection among Family Members in the United States
por: Contopoulos-Ioannidis, Despina G., et al.
Publicado: (2013)

Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination
por: Pastorino, Roberta, et al.
Publicado: (2022)

SARS‐CoV‐2 re‐infection risk in Austria
por: Pilz, Stefan, et al.
Publicado: (2021)

Humoral Immune Response to SARS-CoV-2 in Iceland
por: Gudbjartsson, Daniel F., et al.
Publicado: (2020)

Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS‐CoV‐2 in the endemic phase?
por: Pilz, Stefan, et al.
Publicado: (2022)

Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
por: Cheng, Vincent C.C., et al.
Publicado: (2020)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Assessment of transparency indicators across the biomedical literature: How open is open?
por: Serghiou, Stylianos, et al.
Publicado: (2021)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
por: Laurén, Ida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rsd4c0o5o6hvmrsj038pnl5ssr